Month: February 2020

MONTREAL, Feb. 18, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the fourth quarter and fiscal year ended November 30, 2019, on Tuesday, February 25, 2020.A conference call will be held on February 25, 2020 at 8:30 a.m. (ET) to discuss the results. The call will be hosted by Luc Tanguay, President and Chief Executive Officer. The conference call will be open to questions from financial analysts. Media and other interested individuals are invited to participate in the call on a “listen-only” basis.The conference call can be accessed by dialling 1-877-223-4471 (North America) or 1-647-788-4922 (International). The conference call will also be accessible via webcast at https://onlinexperiences.com/Launch/QReg/ShowUUID%3D9E8A1D54-B4EE-4411-A0E8-D52CEC6A96BA....

MONTRÉAL, 18 févr. 2020 (GLOBE NEWSWIRE) — Theratechnologies inc. («Theratechnologies») (TSX : TH) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers mardi le 25 février 2020 pour le quatrième trimestre et l’exercice financier terminés le 30 novembre 2019.Une conférence téléphonique aura lieu à compter de 8h30 (heure de l’Est) le 25 février 2020 pour discuter des résultats. L’appel sera animé par Luc Tanguay, président et chef de la direction. Les analystes financiers seront invités à poser des questions lors de la conférence téléphonique. Les membres des médias et autres personnes intéressées sont invités à la conférence à titre d’auditeurs uniquement.Pour accéder à la conférence téléphonique, veuillez composer le 1-877-223-4471 (sans frais) ou 1-647-788-4922 (international). L’appel sera également accessible...

OTTAWA, Feb. 18, 2020 (GLOBE NEWSWIRE) — Tetra Bio Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB: TBPMF) a leader in cannabinoid-derived drug discovery and development, is pleased to announce the appointment of Sylvain Chrétien as President of Tetra Bio-Pharma Inc. Mr. Chrétien will report directly to Guy Chamberland, CEO of Tetra.Mr. Chamberland was instrumental in selecting the Company’s first President so that he could devote more time to the regulatory strategies and drug development of Caumz, Qixleef and HCC011. As President, Mr. Chrétien will be responsible for investor relations and preparing Tetra for the commercialization of Caumz and Qixleef.  The CEO and President will continue to promote Tetra and work with the CFO on future financings.“I am thrilled to welcome Sylvain to our senior executive team at this...

NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 9th Annual SVB Leerink Global Healthcare Conference in New York. The presentation is scheduled for Tuesday, February 25, 2020 at 9:00 am ET.The live and archived webcast can be accessed under “Press Releases & Events” in the Investor Relations section of the Company’s website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.About Intra-Cellular TherapiesIntra-Cellular...

Kalamazoo, Michigan, Feb. 18, 2020 (GLOBE NEWSWIRE) — Kalamazoo, Michigan – February 18, 2020 – Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today it has been named one of Fortune’s 2020 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States for a 10th consecutive year. The list recognizes companies that have exceptional workplace cultures and Stryker was ranked #8.  “Being named to the 100 Best Companies to Work For list for a decade is an honor that we attribute to our people and culture,” said Katy Fink, Vice President, Chief Human Resources Officer, Stryker. “Our employees are driven to deliver on our mission to make healthcare better. We celebrate them and their many contributions that make Stryker a great place to work.”Fortune...

Alpharetta, GA, Feb. 18, 2020 (GLOBE NEWSWIRE) — SWM (NYSE: SWM) today announced the signing of a definitive agreement to acquire Tekra, LLC and Trient, LLC (“Tekra and Trient’), converters of high-performance films and substrates, significantly enhancing the Company’s films capabilities.  Tekra and Trient currently operate as divisions of EIS and are based in the Milwaukee, Wisconsin area.  The purchase price is $155 million in cash (subject to certain customary closing adjustments) and the transaction is expected to close before March 31, 2020.Tekra and Trient HighlightsDeep expertise in technical films converting, bringing new capabilities to SWM’s AMS segmentKey end-markets include medical, graphics, electronics, and automotive, bolstering several existing SWM market presences, creating access to new customers, and...

BELTSVILLE, Md., Feb. 18, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the 9th Annual SVB Leerink Global Healthcare Conference in New York on February 25 at 9:00 am.A live audio webcast will be available through the Investors section of the company’s website at www.nextcure.com. A replay of the webcast will be available approximately two hours after the event and archived on the website for 30 days.About NextCure, Inc.NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Through our...

Transaction Valued at Approximately $2.3 BillionAUSTIN, Texas and CHRISTIANSTED, U.S. Virgin Islands, Feb. 18, 2020 (GLOBE NEWSWIRE) — Amherst Residential, LLC (“Amherst Residential”), a privately-owned, vertically-integrated real estate firm, and Front Yard Residential Corporation (“Front Yard” or the “Company”) (NYSE: RESI), two industry leading providers of high-quality and affordable rental homes, announced today that the companies have entered into a definitive merger agreement, whereby Amherst Residential will acquire Front Yard in a transaction valued at approximately $2.3 billion, including debt to be assumed or refinanced.Under the terms of the agreement, Front Yard shareholders will receive $12.50 in cash per share. The per share purchase price represents a premium of approximately 14.2% over the per share closing price...

VANCOUVER, British Columbia, Feb. 18, 2020 (GLOBE NEWSWIRE) — Juggernaut Exploration Ltd. (JUGR.V) (the “Company” or “Juggernaut”) is pleased to report channel sample results from the Goldilocks Zone containing assays of 7.86g/t AuEq over 3.75m true width. This channel was taken over a 3.75m wide section to partially test a 10.5m wide outcrop containing extensive veining and alteration, the channel started in 9.01 g/t AuEq and ended in 10.79 g/t AuEq and remains open. The Goldilocks Zone discovered in 2018 is 190m long by 20 meters wide and extends for 160 m vertical relief. It is located 500 m north of the Yellow Brick Road Gold Zone, and remains open. The Yellow Brick Road Zone was discovered in 2017, mapped for 170 meters and remains open. Channel samples assayed up to 24.55 grams per tonne gold equivalent over 0.3 meters (20.6...

Please find enclosed notice of GN Store Nord A/S’ Annual General Meeting to be held on March 11, 2020, including the agenda and complete proposals.For further information, please contact:Investors and analystsMorten P. ToftVice President – Investor Relations & TreasuryTel: +45 45 75 46 07OrRune SandagerSenior Manager – Investor Relations Tel: +45 45 75 92 57The GN Group is a global leader in intelligent hearing, audio and video collaboration solutions that let you hear more, do more and be more than you ever thought possible. Our pioneering 150-year journey has taken us from telegraph cables to radio waves and intelligent audio engineering. With our unique competences in medical, professional and consumer audio solutions, we strive to meet individual customer needs and transform lives through the power of sound. GN was founded with...